TL;DR
Recent questions regarding the extension of hormone therapy to ovarian suppression and current strategies are reviewed, with a focus on clinical studies such as OlympiA, monarchE, and NATALEE, which currently guide therapeutic decisions.
AI-generated by Semantic Scholar
Authors
Julie Cabal, Céline Lescure, Véronique Dieras, Fanny Le Du
